M1 macrophages have pro‐inflammatory and tumor cell‐killing functions, whereas M2 macrophages can inhibit CD8+ T‐cell activation and promote Treg recruitment through soluble suppressors, thus contributing to the development of tumor immune escape [9, 10, 11]. The gene discussed is CD8A; the disease is neoplasm.